Epstein–Barr virus early antigen diffuse (EBV-EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients

References

• Pons-Estel GJ, Alarcon GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 2010;39:257–68.
   PubMed Web of Science ®Google Scholar
• Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008;358:929–39.
   PubMed Web of Science ®Google Scholar
• Smith PP, Gordon C. Systemic lupus erythematosus: clinical presentations. Autoimmun Rev 2010;10:43–5.
   PubMed Web of Science ®Google Scholar
• von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995;24: 323–58.
   PubMed Web of Science ®Google Scholar
• Munoz LE, Janko C, Schulze C, Schorn C, Sarter K, Schett G, . Autoimmunity and chronic inflammation – two clearance-related steps in the etiopathogenesis of SLE. Autoimmun Rev 2010; 10:38–42.
   PubMed Web of Science ®Google Scholar
• James JA, Neas BR, Moser KL, Hall T, Bruner GR, Sestak AL, . Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 2001;44:1122–6.
   PubMed Web of Science ®Google Scholar
• Gross AJ, Hochberg D, Rand WM, Thorley-Lawson DA. EBV and systemic lupus erythematosus: a new perspective. J Immunol 2005;174:6599–607.
   PubMed Web of Science ®Google Scholar
• Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J, . Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol 2004;172:1287–94.
   PubMed Web of Science ®Google Scholar
• Moon UY, Park SJ, Oh ST, Kim WU, Park SH, Lee SH, . Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther 2004;6:R295–302.
   PubMed Web of Science ®Google Scholar
• Yu SF, Wu HC, Tsai WC, Yen JH, Chiang W, Yuo CY, . Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan. Med Microbiol Immunol 2005;194:115–20.
   PubMed Web of Science ®Google Scholar
• Berner BR, Tary-Lehmann M, Yonkers NL, Askari AD, Lehmann PV, Anthony DD. Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE. Cell Immunol 2005;235:29–38.
   PubMed Web of Science ®Google Scholar
• Tsokos GC, Magrath IT, Balow JE. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus. J Immunol 1983;131:1797–801.
   PubMed Web of Science ®Google Scholar
• Auwaerter PG. Infectious mononucleosis in middle age. J Am Med Assoc 1999;281:454–9.
   PubMed Web of Science ®Google Scholar
• Tattevin P, Le TY, Minjolle S, Person A, Chapplain JM, Arvieux C, . Increasing incidence of severe Epstein-Barr virus-related infectious mononucleosis: surveillance study. J Clin Microbiol 2006;44:1873–4.
   PubMed Web of Science ®Google Scholar
• Joseph AM, Babcock GJ, Thorley-Lawson DA. Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils. J Virol 2000;74:9964–71.
   PubMed Web of Science ®Google Scholar
• Babcock GJ, Hochberg D, Thorley-Lawson AD. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 2000;13:497–506.
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson DA. Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 2001;1:75–82.
   PubMed Web of Science ®Google Scholar
• Schepers A, Pich D, Hammerschmidt W. Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1. Virology 1996;220:367–76.
   PubMed Web of Science ®Google Scholar
• Holley-Guthrie EA, Quinlivan EB, Mar EC, Kenney S. The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner. J Virol 1990;64:3753–9.
   PubMedGoogle Scholar
• Zhang Q, Hong Y, Dorsky D, Holley-Guthrie E, Zalani S, Elshiekh NA, . Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: effects on EBV transcription and lytic replication. J Virol 1996;70:5131–42.
   PubMed Web of Science ®Google Scholar
• Quinlivan EB, Holley-Guthrie EA, Norris M, Gutsch D, Bachenheimer SL, Kenney SC. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1. Nucleic Acids Res 1993;21:1999–2007.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Holley-Guthrie E, Ge JQ, Dorsky D, Kenney S. The Epstein-Barr virus (EBV) DNA polymerase accessory protein, BMRF1, activates the essential downstream component of the EBV oriLyt. Virology 1997;230:22–34.
   PubMed Web of Science ®Google Scholar
• Wong KM, Levine AJ. Identification and mapping of Epstein-Barr virus early antigens and demonstration of a viral gene activator that functions in trans. J Virol 1986;60:149–56.
   PubMedGoogle Scholar
• Luka J, Miller G, Jornvall H, Pearson GR. Characterization of the restricted component of Epstein-Barr virus early antigens as a cytoplasmic filamentous protein. J Virol 1986;58:748–56.
   PubMedGoogle Scholar
• Chen LW, Lin LS, Chang YS, Liu ST. Functional analysis of EA-D of Epstein-Barr virus. Virology 1995;211:593–7.
   PubMedGoogle Scholar
• Tsurumi T. Purification and characterization of the DNA-binding activity of the Epstein-Barr virus DNA polymerase accessory protein BMRF1 gene products, as expressed in insect cells by using the baculovirus system. J Virol 1993;67:1681–7.
   PubMedGoogle Scholar
• Tsurumi T, Daikoku T, Kurachi R, Nishiyama Y. Functional interaction between Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunit in vitro. J Virol 1993;67:7648–53.
   PubMedGoogle Scholar
• Li JS, Zhou BS, Dutschman GE, Grill SP, Tan RS, Cheng YC. Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activity. J Virol 1987;61: 2947–9.
   PubMed Web of Science ®Google Scholar
• Daibata M, Sairenji T. Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells. Virology 1993;196:900–4.
   PubMedGoogle Scholar
• Jones JF, Straus SE. Chronic Epstein-Barr virus infection. Annu Rev Med 1987;38:195–209.
   PubMed Web of Science ®Google Scholar
• Toussirot E, Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol 2008;22:883–96.
   PubMed Web of Science ®Google Scholar
• Ooka T, de Turenne-Tessier M, Stolzenberg MC. Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases. Springer Semin Immunopathol 1991;13:233–47.
   PubMedGoogle Scholar
• Schwarzmann F, Jager M, Hornef M, Prang N, Wolf H. Epstein-Barr viral gene expression in B-lymphocytes. Leuk Lymphoma 1998;30:123–9.
   PubMed Web of Science ®Google Scholar
• Chen DY, Chen YM, Lan JL, Chen HH, Hsieh CW, Wey SJ, . Polymyositis/dermatomyositis and nasopharyngeal carcinoma: the Epstein-Barr virus connection? J Clin Virol 2010; 49:290–5.
   PubMed Web of Science ®Google Scholar
• Huggins ML, Todd I, Powell RJ. Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosus. Rheumatol Int 2005;25:183–7.
   PubMed Web of Science ®Google Scholar
• Berkun Y, Zandman-Goddard G, Barzilai O, Boaz M, Sherer Y, Larida B, . Infectious antibodies in systemic lupus erythematosus patients. Lupus 2009;18:1129–35.
   PubMed Web of Science ®Google Scholar
• Stratta P, Canavese C, Ciccone G, Santi S, Quaglia M, Ghisetti V, . Correlation between cytomegalovirus infection and Raynaud’s phenomenon in lupus nephritis. Nephron 1999;82:145–54.
   PubMed Web of Science ®Google Scholar
• Lu JJ, Chen DY, Hsieh CW, Lan JL, Lin FJ, Lin SH. Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan. Lupus 2007;16:168–75.
   PubMed Web of Science ®Google Scholar
• Chen CJ, Lin KH, Lin SC, Tsai WC, Yen JH, Chang SJ, . High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. J Rheumatol 2005;32:44–7.
   PubMed Web of Science ®Google Scholar
• Parks CG, Cooper GS, Hudson LL, Dooley MA, Treadwell EL, St Clair EW, . Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis Rheum 2005;52:1148–59.
   PubMedGoogle Scholar
• Esen BA, Yilmaz G, Uzun S, Ozdamar M, Aksozek A, Kamali S, . Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study. Rheumatol Int 2012;32:79–83.
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard G, Berkun Y, Barzilai O, Boaz M, Blank M, Ram M, . Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease. Ann N Y Acad Sci 2009;1173:658–63.
   PubMed Web of Science ®Google Scholar
• Lau CS, Yuen KY, Chan KH, Wong RW. Lack of evidence of active lytic replication of Epstein-Barr and cytomegaloviruses in patients with systemic lupus erythematosus. Chin Med J (Engl) 1998;111:660–5.
   PubMedGoogle Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
   PubMed Web of Science ®Google Scholar
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23: 581–90.
   PubMed Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, . Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 2002;61:554–8.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, . The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Liu MT, Lin LS, Yu Y, Chung TT, Hsu CY, Chen JT, . Use of recombinant Epstein-Barr virus early antigen for detection of antibody in patients with nasopharyngeal carcinoma. Zhonghua Yi Xue Za Zhi (Taipei) 1996;57:7–15.
   PubMedGoogle Scholar
• Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ, . Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma. Oral Oncol 2008;44:784–92.
   PubMedGoogle Scholar
• Paramita DK, Fachiroh J, Artama WT, van Benthm E, Haryana SM, Middeldorp JM. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma. J Med Virol 2007;79:1710–21.
   PubMed Web of Science ®Google Scholar